Corporate sustainability leaders spoke about innovation and partnering with the public sector during a panel at the inaugural ...

GlaxoSmithKline Pharmaceutical Sdn Bhd (GSK) today announced that the Arexvy vaccine (MAL24086007ARZ) has been approved in Malaysia for respiratory syncytial virus (RSV). RSV is a common respiratory ...

Sanofi has received two separate bids from private equity firms for its consumer health unit, which could be valued at 15 ...

A groundbreaking study will investigate Parkinson’s disease in unprecedented detail, with the aim of discovering a cure for the condition.

GSK PLC GSK shares inched up 0.20% to £15.31 Tuesday, on what proved to be an all-around favorable trading session for the ...

（吉隆坡24日讯）葛兰素史克制药有限公司（GSK）宣布，Arexvy 疫苗（MAL24086007ARZ）已在马来西亚获得批准用于治疗呼吸道合胞病毒（RSV）。RSV是一种常见的呼吸道病毒，可引起下呼吸道疾病（LRTD）和老年人肺炎等严重的临床影响。马拉工艺大学苏丹阿都拉教学医院副院长兼呼吸内科顾问阿末依祖亚努丁表示，RSV可能会造成严重影响，尤其是对患有哮喘、慢性阻塞性肺病（COPD）和慢性心力 ...

If approved, AZN's Fasenra will be the second biologic approved in the European Union to treat eosinophilic granulomatosis ...

Biogen and Belgian partner UCB said on Tuesday their experimental lupus treatment met the main goal of a late-stage trial in ...

The NHS is offering autumn Covid boosters to the most vulnerable in October. Many pharmacies also now sell the Covid jab ...

(Alliance News) - GSK PLC on Tuesday announced a new positive opinion from the EU's European Medicine Agency's Committee for Medicinal Products for Human Use. The London-based pharmaceutical company ...

After lagging overseas stocks for over 10 years, our writer investigates whether FTSE 100 shares could be the smart place for ...

Antibiotic resistance is a threat to modern healthcare. Nine European research projects have published in Nature Reviews Drug Discovery an article emphasizing the need to maintain expertise and ...